MPLT · NASDAQ
MapLight Therapeutics (MPLT) Stock Price & Fundamentals
MapLight Therapeutics (MPLT) closed at $379.40 on Oct 9, 2026, down 0.82% from the previous close of $382.53.
Share price, past year
1Y +5.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $379.40 |
| Sep 30, 2026 | $386.34 |
| Aug 31, 2026 | $392.47 |
| Jul 31, 2026 | $393.79 |
| Jun 30, 2026 | $381.87 |
| May 29, 2026 | $387.69 |
| Apr 30, 2026 | $364.64 |
| Mar 31, 2026 | $375.30 |
| Feb 27, 2026 | $374.14 |
| Jan 30, 2026 | $392.18 |
| Dec 31, 2025 | $389.18 |
| Nov 28, 2025 | $385.72 |
| Oct 31, 2025 | $356.56 |
Key statistics
- Market cap
- $17.24B
- P/E (TTM)
- 8.0
- EPS (TTM)
- $47.22
- Net income (TTM)
- −$229.83M
- Shares outstanding
- 45.4M
- 52-week range
- $348.11 – $406.91
MapLight Therapeutics's market cap is $17.24B, based on a share price of $379.40 and 45.4M shares outstanding as of Jun 30, 2026.
Financials
MapLight Therapeutics's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
MapLight Therapeutics reported a net loss of $161.15M in fiscal 2025.
Company profile
- Name
- MapLight Therapeutics, Inc.
- Ticker
- MPLT
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 800 Chesapeake Drive, Redwood City, CA 94063
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001770069
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Jul 27, 2026
- Jun 24, 2026
- Jun 22, 2026
- Jun 18, 2026
- May 14, 2026
- May 14, 2026
Frequently asked questions
What is MapLight Therapeutics's stock price?
MapLight Therapeutics (MPLT) closed at $379.40 on Oct 9, 2026, down 0.82% from the previous close of $382.53.
What is MapLight Therapeutics's market cap?
MapLight Therapeutics's market cap is $17.24B, based on a share price of $379.40 and 45.4M shares outstanding as of Jun 30, 2026.
What is MPLT's P/E ratio?
MapLight Therapeutics's price-to-earnings ratio is 8.0, based on trailing twelve-month diluted EPS of $47.22.
Does MapLight Therapeutics pay a dividend?
MapLight Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from MapLight Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures